About The Study
Study Location: San Antonio, TX
Esophagitis is a condition where the esophagus, the tube that delivers food from your mouth to your stomach, becomes inflamed. This painful condition is often caused by acid regurgitation and is associated with moderate-to-severe heartburn.
Researchers are conducting a study to evaluate the safety and effectiveness of an investigational drug, compared to a PPI control medication like Prilosec, in healing Erosive Esophagitis (EE). Many adults who struggle with frequent heartburn and regurgitation may not know that they have EE; potential participants in this study will receive an upper GI endoscopy to determine their eligibility.
To qualify, participants must*:
- Be 18 years of age or older
- Have experienced both heartburn and regurgitation within 7 days of first study visit
- Be willing and able to undergo an upper GI endoscopy to determine their eligibility
*Additional criteria apply to participate. A study coordinator will be able to discuss your eligibility with you.
There is no cost to participate and health insurance is not required to participate. Eligible participants will receive the investigational study drug or PPI control drug and all study-related assessments at no cost. Compensation for time and/or travel may also be provided.
So far - So good!
To learn more about this study and how you can participate, fill out the form below for a study coordinator to contact you.
We're sorry, but you are not eligible at this time...
You can also enter your information below if you would like to be contacted about future clinical research opportunities. Contact your healthcare provider if you have any medical questions.